Open original FDA record ↗Recall record
- FDA identifier
- Z-0614-2013
- Company in FDA record
- Roche Molecular Systems, Inc.
- FDA classification date
- Dec 23, 2012
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 17, 2026
- Recall classification
- Class II
Reason stated in the source
Certain COBAS AmpliPrep instruments using AMPILINK software v.3.3.4 had the sample clot detection flagging feature disabled during quality control release resulting in samples that may not be flagged as having clots.
Source facts
- Action
- Roche sent an Urgent Medical Device Correction notification/Fax Back forms dated 10/11/12 to potentially affected customers. The letter identified the affected product, the issue, clinical significance, workaround, and required actions, along with contact information. Customers are to use the workaround until their Roche FSE has performed a Master Initialization on their affected instruments. Also, the letter should be filed for future reference. Questions should be directed to Roche Molecular Diagnostics Technical Support at 1-800-526-1247.
- Initiated
- 2012-10-11
- Root cause
- Device Design
- Terminated
- 2013-09-11
- Distribution
- Distributed in the states of GA, CA, NC, and MN.
- Recall number
- Z-0614-2013
- Recall status
- Terminated
- CDRH record ID
- 114824
- FDA classified
- 2012-12-23
- Recall event number
- 63814